Table 3.
Main Analysis | Second Asthma Diagnosis | Proximity cohort | |||||||
---|---|---|---|---|---|---|---|---|---|
OR | 95% CI | P-value | OR | 95% CI | P-value | OR | 95% CI | P-value | |
Race/ethnicity (ref non-Hispanic White) | |||||||||
Non-Hispanic Asian | 1.13 | 1.05-1.21 | < 0.001 | 1.12 | 1.03-1.21 | 0.006 | 1.26 | 1.10-1.45 | 0.001 |
Non-Hispanic Black | 1.67 | 1.62-1.73 | < 0.001 | 1.68 | 1.61-1.74 | < 0.001 | 1.77 | 1.63-1.92 | < 0.001 |
Hispanic | 1.2 | 1.15-1.26 | < 0.001 | 1.3 | 1.23-1.37 | < 0.001 | 1.26 | 1.11-1.42 | < 0.001 |
Missing | 0.95 | 0.91-0.99 | 0.026 | 0.99 | 0.94-1.04 | 0.651 | 1.12 | 0.97-1.30 | 0.128 |
Other | 1.1 | 1.00-1.21 | 0.047 | 1.14 | 1.02-1.26 | 0.016 | 1.31 | 1.06-1.62 | 0.012 |
Male gender | 1.18 | 1.15-1.21 | < 0.001 | 1.16 | 1.13-1.19 | < 0.001 | 1.09 | 1.05-1.14 | < 0.001 |
Prematurity (<34 weeks) | 1.21 | 1.15-1.27 | < 0.001 | 1.17 | 1.11-1.24 | < 0.001 | 1.09 | 1.00-1.18 | 0.04 |
Food allergy | 1.27 | 1.21-1.32 | < 0.001 | 1.27 | 1.22-1.33 | < 0.001 | 1.28 | 1.18-1.39 | < 0.001 |
Allergic rhinitis | 2.01 | 1.96-2.08 | < 0.001 | 2.05 | 1.99-2.12 | < 0.001 | 1.83 | 1.72-1.95 | < 0.001 |
Eczema | 1 | 0.97-1.02 | 0.747 | 1.05 | 1.02-1.08 | < 0.001 | 1.2 | 1.15-1.25 | < 0.001 |
Any wheeze episode | 28.56 | 27.42-29.75 | < 0.001 | 48.92 | 45.69-52.38 | < 0.001 | 30.99 | 28.49-33.72 | < 0.001 |
Additional wheeze episodes | 1.37 | 1.36-1.38 | < 0.001 | 1.47 | 1.46-1.48 | < 0.001 | 1.54 | 1.51-1.56 | < 0.001 |
Any cough episodes | 1.01 | 0.97-1.03 | 0.95 | 1.01 | 0.98-1.04 | 0.635 | 0.92 | 0.88-0.97 | < 0.001 |
Additional cough episodes | 1.06 | 1.04-1.07 | < 0.001 | 1.03 | 1.01-1.04 | < 0.001 | 1 | 0.98-1.03 | 0.79 |
Proportion diagnosed with asthma | 21.41% | 17.14% | 27.72% | ||||||
Variance from GLMM† | 0.1413 | 0.1621 | 0.0047 | ||||||
ICC‡ | 0.0412 | 0.0470 | 0.0014 |
A11 analyses adjusted for age. See Supplemental Table 2 in Appendix for ORs for 3-month age intervals.
Generalized linear mixed model
Intraclass correlation coefficient